These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 13434530

  • 1. Drug and milieu effects with chronic schizophrenics.
    RASHKIS HA, SMARR ER.
    AMA Arch Neurol Psychiatry; 1957 Jul; 78(1):89-94. PubMed ID: 13434530
    [No Abstract] [Full Text] [Related]

  • 2. Shifts along the alert-repose continuum during remission of catatonic stupor with amobarbital.
    STEVENS JM, DERBYSHIRE AJ.
    Psychosom Med; 1958 Jul; 20(2):99-107. PubMed ID: 13542708
    [No Abstract] [Full Text] [Related]

  • 3. Combination reserpine-methylphenidylacetate in epileptics with psychosis.
    HOLT EK, NISWANDER GD.
    Dis Nerv Syst; 1957 Jan; 18(1):11-5. PubMed ID: 13397451
    [No Abstract] [Full Text] [Related]

  • 4. Reserpine and methylphenidylacetate effects on socialization and activity.
    NISWANDER GD, HASLERUD GM, BRODY N, CASEY TM.
    J Nerv Ment Dis; 1957 Jan; 125(1):51-6. PubMed ID: 13481697
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined ritalin and serpasil therapy in chronic psychoses.
    WODRASKA TW, SAUNDERS JC, KLINE NS.
    Dis Nerv Syst; 1958 Mar; 19(3):122-36. PubMed ID: 13524119
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of hypertension using reserpine combined with a new analeptic agent, methyl-phenidylacetate hydrochloride; limitations of usefulness.
    ACHOR RW, BERGE KG.
    Antibiotic Med Clin Ther (New York); 1957 Oct; 4(10):602-8. PubMed ID: 13470833
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative therapeutic effect of serpasil-ritalin combination].
    CHRISTE R.
    Schweiz Med Wochenschr; 1956 Nov 17; 86(46):1318-21. PubMed ID: 13390870
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic experiments on the symptomatic treatment of psychoneurotic disorders].
    MIESCHER P.
    Praxis; 1956 Nov 08; 45(45):1041-3. PubMed ID: 13389152
    [No Abstract] [Full Text] [Related]

  • 13. [Considerations on the use of reserpine & phenyl (alpha-piperidyl) acetic acid in the treatment of preoperative anxiety states].
    ALAMANNI V.
    Riv Ostet Ginecol; 1957 Mar 08; 12(3):152-9. PubMed ID: 13466902
    [No Abstract] [Full Text] [Related]

  • 14. [Further results of new therapy of Parkinsonian syndromes; therapeutic action of 3-phenyl-3-b-diethylamino-ethyl-2-6-dioxy-piperidine hydrochloride administered alone and with reserpine and ritalin].
    GIBERTI F, GIANNIOTTI G, SPIZZIRRI S.
    Gazz Med Ital; 1957 Sep 08; 116(9):404-7. PubMed ID: 13480469
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Action of methyl-phenidylacetate (ritalin) and reserpine in behavior disorders in children and adults.
    ZIMMERMAN FT, BURGEMEISTER BB.
    Am J Psychiatry; 1958 Oct 08; 115(4):323-8. PubMed ID: 13583220
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hypertension management in Los; experiences with serpatonil].
    HEYDECKE KH.
    Sven Lakartidn; 1956 Oct 19; 53(42):2754-5. PubMed ID: 13380770
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Observations on neurotic depressions with reference to a combined serpasil-ritalin treatment].
    BARISON F, MASSIGNAN L.
    Rass Neuropsichiatr; 1956 Oct 19; 10(5-6):198-209. PubMed ID: 13494754
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.